Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies

被引:26
作者
Ashok, Abhishekh H. [1 ,2 ,3 ]
Mizuno, Yuya [3 ,4 ]
Howes, Oliver D. [1 ,2 ,3 ]
机构
[1] MRC London Inst Med Sci Ctr LMS, Psychiat Imaging Grp, Du Cane Rd, London W12 0NN, England
[2] Imperial Coll London, ICS, Fac Med, Psychiat Imaging Grp, Du Cane Rd, London, England
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, 16 De Crespigny Pk, London SE5 8AB, England
[4] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
基金
英国医学研究理事会; 英国惠康基金;
关键词
Tobacco smoking; Dopamine; Molecular imaging studies; Meta-analysis; NICOTINIC ACETYLCHOLINE-RECEPTORS; SEROTONIN TRANSPORTER AVAILABILITY; CIGARETTE-SMOKING; SEX-DIFFERENCES; IN-VIVO; SYNAPTIC DOPAMINE; VENTRAL STRIATUM; DOUBLE-BLIND; D1; RECEPTOR; RELEASE;
D O I
10.1007/s00213-019-05196-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
RationaleAbout 1.1 billion people smoke tobacco globally and tobacco-related health care costs 1.8% of GDP in many countries. The majority of people are unable to quit smoking despite pharmacological intervention, highlighting the need to understand the pathophysiology associated with tobacco smoking to aid the development of new therapeutics. The reinforcing effects of tobacco smoking are thought to be mediated by the dopamine system. However, the nature of dopamine dysfunction seen in smokers is unclear.ObjectiveTo determine the nature and robustness of the evidence for dopaminergic alterations in smokers.MethodsThe entire MEDLINE, EMBASE, and PsycINFO databases were searched for studies from inception date to November 18, 2018. In vivo human molecular imaging studies of dopamine measures (dopamine synthesis or release capacity, transporter levels, receptor levels) in tobacco smokers were selected. Demographic, clinical, and imaging measures were extracted from each study and meta-analyses, and sensitivity analyses were conducted.ResultsFourteen studies met inclusion criteria comprising a total sample of 219 tobacco smokers and 297 controls. The meta-analysis showed a significant reduction in dopamine transporter availability in the smokers relative to controls with an effect size of -0.72 ([95% CI, -1.38 to -0.05], p=0.03). However, there was no difference in D2/3 receptor availability in smokers relative to controls (d=-0.16 ([95% CI, -0.42 to 0.1], p=0.23). There were insufficient studies for meta-analysis of other measures. However, findings from the published studies indicated blunted dopamine release and lower D1 receptor availability, while findings for dopamine synthesis capacity were inconsistent.ConclusionOur data indicate that striatal dopamine transporter availability is lower but D2/3 receptors are unaltered in smokers relative to controls. We discuss the putative mechanisms underlying this and their implications.
引用
收藏
页码:1119 / 1129
页数:11
相关论文
共 88 条
[1]   Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naive Schizophrenic Subjects [J].
Abi-Dargham, Anissa ;
van de Giessen, Elsmarieke ;
Slifstein, Mark ;
Kegeles, Lawrence S. ;
Laruelle, Marc .
BIOLOGICAL PSYCHIATRY, 2009, 65 (12) :1091-1093
[2]   Effects of smoking on D2/D3 striatal receptor availability in alcoholics and social drinkers [J].
Albrecht, Daniel S. ;
Kareken, David A. ;
Yoder, Karmen K. .
BRAIN IMAGING AND BEHAVIOR, 2013, 7 (03) :326-334
[3]   Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine A Systematic Review and Meta-analysis [J].
Ashok, Abhishekh H. ;
Mizuno, Yuya ;
Volkow, Nora D. ;
Howes, Oliver D. .
JAMA PSYCHIATRY, 2017, 74 (05) :511-519
[4]  
Balfour DJK, 2015, CURR TOP BEHAV NEURO, V24, P1, DOI 10.1007/978-3-319-13482-6_1
[5]   The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride [J].
Barrett, SP ;
Boileau, I ;
Okker, J ;
Pihl, RO ;
Dagher, A .
SYNAPSE, 2004, 54 (02) :65-71
[6]   Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics [J].
Benowitz, Neal L. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 :57-71
[7]   The effects of Δ9-tetrahydrocannabinol on the dopamine system [J].
Bloomfield, Michael A. P. ;
Ashok, Abhishekh H. ;
Volkow, Nora D. ;
Howes, Oliver D. .
NATURE, 2016, 539 (7629) :369-377
[8]   Dopamine Function in Cigarette Smokers: An [18F]-DOPA PET Study [J].
Bloomfield, Michael A. P. ;
Pepper, Fiona ;
Egerton, Alice ;
Demjaha, Arsime ;
Tomasi, Gianpaolo ;
Mouchlianitis, Elias ;
Maximen, Levi ;
Veroneses, Mattia ;
Turkheimer, Federico ;
Selvaraj, Sudhakar ;
Howes, Oliver D. .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 (10) :2397-2404
[9]   Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms [J].
Bloomfield, Michael A. P. ;
Morgan, Celia J. A. ;
Egerton, Alice ;
Kapur, Shitij ;
Curran, H. Valerie ;
Howes, Oliver D. .
BIOLOGICAL PSYCHIATRY, 2014, 75 (06) :470-478
[10]   Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders [J].
Breier, A ;
Su, TP ;
Malhotra, AK ;
Elman, I ;
Adler, CM ;
Weisenfeld, NI ;
Pickar, D .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (04) :340-345